SERGI, DOMENICO
 Distribuzione geografica
Continente #
NA - Nord America 511
EU - Europa 300
AS - Asia 77
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 891
Nazione #
US - Stati Uniti d'America 502
SE - Svezia 188
IT - Italia 56
SG - Singapore 33
FI - Finlandia 22
IN - India 18
CN - Cina 12
DE - Germania 12
CA - Canada 8
ID - Indonesia 6
HK - Hong Kong 4
IE - Irlanda 4
RU - Federazione Russa 4
FR - Francia 3
GB - Regno Unito 3
BG - Bulgaria 2
AU - Australia 1
BE - Belgio 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
NO - Norvegia 1
RO - Romania 1
TH - Thailandia 1
TR - Turchia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 891
Città #
Stockholm 154
Fairfield 96
Ashburn 35
Houston 31
Chandler 29
Woodbridge 29
Cambridge 28
Wilmington 28
Seattle 27
Singapore 26
Santa Clara 18
Dearborn 17
Rome 17
Helsinki 16
San Paolo di Civitate 15
Millbury 11
Princeton 11
Ann Arbor 9
Lawrence 8
Plano 8
San Diego 8
Milan 7
Jakarta 6
New York 6
Norwalk 5
Sacramento 5
Andover 4
Bremen 4
Dublin 4
Hong Kong 4
Los Angeles 4
Ottawa 4
Bühl 3
Toronto 3
Beijing 2
Boardman 2
Bovisio-Masciago 2
Dallas 2
Guangzhou 2
Moscow 2
Redwood City 2
Sofia 2
Bern 1
Brussels 1
Buffalo 1
Cadelbosco di Sopra 1
Chengdu 1
Falkenstein 1
Fremont 1
Frosinone 1
Groningen 1
Guidonia Montecelio 1
Handan 1
Leawood 1
Muizenberg 1
Naples 1
Oslo 1
Phoenix 1
Portogruaro 1
Quzhou 1
Shenyang 1
Suzhou 1
Trumbull 1
Winnipeg 1
Zanjan 1
Totale 719
Nome #
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 188
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: a real-world experience 122
Metabolic determinants and anthropometric indicators impact clinical-pathological features in epithelial ovarian cancer patients 87
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 86
Neoadjuvant sequential docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab. The DECT trial 72
Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study 71
Non-pegylated liposomal doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients 67
Metformin and breast cancer: basic knowledge in clinical context 63
null 52
Observational multicenter study on the prognostic relevance of coagulation activation in risk assessment and stratification in locally advanced breast cancer. Outline of the arias trial 42
Circulating hpv dna in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives 38
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 34
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study 24
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study 19
Totale 965
Categoria #
all - tutte 2.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020120 0 0 0 0 0 33 22 20 20 9 8 8
2020/202149 10 5 2 2 2 9 0 1 6 9 2 1
2021/2022127 0 2 14 4 23 6 2 15 5 7 31 18
2022/2023151 29 25 7 14 29 18 1 11 11 2 4 0
2023/202479 4 11 4 8 8 10 1 15 0 10 6 2
2024/2025258 161 16 20 13 32 16 0 0 0 0 0 0
Totale 965